ciRS-7 acts as a tumor promoter by regulating the miR-139-3p/TAGLN axis and activating the PI3K/AKT signaling pathway to promote RCC progression and metastasis.
ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma.